JANX

Janux Therapeutics (JANX)

About Janux Therapeutics (JANX)

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Details

Daily high

$13.38

Daily low

$12.42

Price at open

$12.45

52 Week High

$41.06

52 Week Low

$12.12

Market cap

786.1M

Dividend yield

0.00%

Volume

1.8M

Avg. volume

1.7M

P/E ratio

-7.80

Janux Therapeutics News